Tehran: Iran’s Food and Drug Administration (FDA) spokesman Dr Kianoush Jahanpour said five countries, including two European countries, have requested large-scale importation of five Iranian COVID-19 vaccines produced in Iran.
Dr Jahanpour said five Iranian COVID-19 vaccine companies have been producing 20 million doses of COVID-19 vaccines per month since April 2021.
According to the Iranian Ministry of Health, among more than 12 different Iranian companies that have been trying to produce the COVID-19 vaccine since the start of the COVID-19 pandemic, five Iranian companies have started production of the COVID-19 vaccines. These five major projects include the production of a COVID-19 vaccine at the Institut Pasteur in Tehran whose serial production began in April 2021. After that, the COVID-19 vaccine from the Barekat Foundation, Tehran began production series of its VOC-Iran Barekat vaccine and has created its own production line.
With these two COVID-19 vaccine production lines, the COVID-19 vaccine produced by Razi Vaccine and Serum Research Institute, Tehran and the other, namely the Fakhra COVID-19 vaccine produced by the Ministry of Defense of Iran have started production, the health ministry said.
Five COVID-19 vaccines produced in Iran
Iranian Health Minister Dr Saeed Namaki said Iran has successfully produced five COVID-19 vaccines which are now injected into Iranian citizens and also being imported into various countries. Iran’s total population is only 80 million, and by August 2021, most of the eligible Iranian population will receive doses of the COVID-19 vaccine.
So far, the Iranian Food and Drug Administration has issued an emergency consumption license for Russian Sputnik V, Chinese SinoFarm and South Korean AstraZeneca vaccines and their doses have been administered to Iranian citizens since the beginning of April. 2021.
The Russian Sputnik V vaccine production line is due to be launched in Iran by July 2021 with the cooperation of an Iranian pharmaceutical company.
The first industrial production line of the COV-Iran Barekat COVID-19 vaccine, one of the five COVID-19 vaccines developed nationally in Iran, was launched on May 12, 2021 with the capacity to produce 3 million doses per month and one million doses have been delivered to Iran’s health ministry by May 23, 2021.
The second production line of the COV-Iran Barekat COVID-19 vaccine with the capacity to produce up to 17 million doses in one month is under construction and is expected to be launched in early June 2021. The production of the COV-Iran Barekat COVID-19 vaccine 19 would reach 12 to 15 million doses by the end of August 2021.
Iran aims to become most vaccinated country by August
As of mid-September, around 30 million doses of the COV-Iran Barekat COVID-19 vaccine are said to be produced and delivered to the Iranian Ministry of Health. By August 2021, Iran would become the most vaccinated country in the world.
All the achievements have been made by Iran despite the US sanctions imposed on Iran since 1979 which had hampered the supply of raw materials. Iranian companies working on emerging technologies have joined forces to remove obstacles by focusing on domestic potentials and talents. Since the start of the COVID-19 pandemic, 12 different Iranian companies working on emerging technologies have started their extensive scientific research to produce the COVID-19 vaccine, and five Iranian companies have successfully started industrial production of COVID-19. vaccines.